Revenue and Growth - Revenue increased from $379.8 million in 2024 to $427.5 million in 2025, reflecting a 12.6% year-over-year growth driven by a 16.5% increase in sales volume[419]. - The Asia-Pacific region accounted for 42% of total revenue in 2025, while Europe accounted for 49%, indicating a strategic shift towards higher-margin opportunities in the European commercial vehicle sectors[403]. Profitability and Expenses - Gross profit margin decreased to 28.6% in 2025 from 31.5% in 2024, primarily due to a $32.5 million inventory impairment charge[421]. - General and administrative expenses decreased by $23.7 million, or 29.0%, in 2025 compared to 2024, driven by reduced share-based compensation expenses[422]. - Research and development expenses decreased by $7.0 million, or 16.9%, in 2025 compared to 2024, primarily due to a decrease in share-based compensation expenses[423]. - The impairment loss of long-lived assets decreased by $89.0 million, or 95.6%, in 2025 compared to 2024[425]. Cash Flow and Financing - As of December 31, 2025, the company had cash, cash equivalents, and restricted cash totaling $169.2 million, with $105.0 million in cash and cash equivalents[430]. - The company secured $85.7 million in bank loans during the year ended December 31, 2025, and generated $75.9 million in net cash from operating activities, with an order backlog of $196.1 million expected to be fulfilled in 2026 and 2027[434]. - Net cash provided by operating activities increased by $73.1 million to $75.9 million for the year ended December 31, 2025, compared to $2.8 million in 2024, driven by a $49.9 million increase in net income and a $23.2 million net improvement in operating assets and liabilities[448]. - The company plans to utilize its Controlled Equity Offering Sales Agreement to raise additional capital, having already received $27.9 million in net proceeds[434]. - The company is currently unable to repatriate cash from China to fund U.S. operations or the Clarksville expansion due to regulatory restrictions and is seeking alternate sources of capital[442]. Capital Expenditures and Investments - Capital expenditures amounted to $38.7 million for the year ended December 31, 2025, primarily related to the Huzhou Phase 3.2 expansion, funded by localized borrowings and cash flow from China operations[440]. - The company experienced a net cash outflow of $16.0 million in investing activities for the year ended December 31, 2025, primarily due to capital expenditures for manufacturing facility expansions[449]. - The company reported a net cash used in financing activities of $2.7 million for the year ended December 31, 2025, a decrease of $40.3 million compared to the previous year[450]. Credit Risk Management - Credit risk primarily relates to trade receivables, restricted cash, cash equivalents, and amounts due from related parties[469]. - A hypothetical 100-basis-point increase in the expected loss rate on financing receivables would increase the allowance for credit losses by approximately $0.8 million as of December 31, 2025[470]. - A dedicated credit management team is responsible for establishing credit limits, approving credit terms, and implementing collection strategies[471]. - The company reviews the recoverability of outstanding balances at each reporting period and ensures adequate impairment provisions are recorded[471]. - The company considers its overall credit risk exposure to be significantly mitigated due to robust credit risk management practices[472]. Seasonal Trends - Historically, higher sales volumes are observed in the third and fourth fiscal quarters compared to the first and second quarters[473]. - The company continues to monitor sales trends and market conditions to understand the impact of seasonal demand fluctuations[473].

Business Segments - The Company operates through two reportable segments: title insurance issuance and tax-deferred real property exchange services[12]. - The Company's exchange services division, ITEC and ITAC, derives income from fees for handling exchange transactions and interest on client deposits[31]. - The Company issues title insurance policies directly and through a network of agents, with the ability to attract and retain agents being a key growth determinant[133]. Title Insurance Revenue - Title insurance premiums are recognized as revenue at the closing of related transactions, with agents retaining a majority of the premium as commission[22]. - Premiums from title insurance written in North Carolina, Texas, South Carolina, Georgia, and Florida represent the largest revenue source for the title insurance segment[26]. - In 2025, North Carolina, Texas, Georgia, South Carolina, and Florida represented 35.3%, 27.1%, 8.6%, 8.1%, and 6.4% of total premiums written by the Company, respectively[70]. - Investors Title Company reported total revenues from the title segment accounted for 90.2% of the Company's revenues in 2025[130]. - Title insurance revenues accounted for 90.2% of total revenues in 2025, amounting to $246.1 million, compared to 91.2% in 2024 and 89.4% in 2023[173]. Financial Performance - The Company’s net income for 2025 was $35.2 million, compared to $31.1 million in 2024 and $21.7 million in 2023, showing a strong growth trajectory[171]. - Total revenues for 2025 reached $272.8 million, a 5.8% increase from $258.3 million in 2024, and up from $224.8 million in 2023[171]. - The Company’s total operating expenses for 2025 were $228.2 million, an increase from $218.8 million in 2024, driven by higher commissions and other operational costs[171]. - The provision for income taxes was $9.4 million for 2025, $8.4 million for 2024, and $4.5 million for 2023[210]. - The effective income tax rates were 21.0% for 2025, 21.3% for 2024, and 17.3% for 2023, differing from the U.S. federal statutory rate of 21%[210]. Claims and Reserves - Title insurance claims can be complex and are influenced by economic conditions, with reserve estimates subject to variability[20]. - The reserve for claims as of December 31, 2025, totaled $38.1 million, with approximately $3.5 million reserved for specific claims and $34.6 million for incurred but not reported claims[148]. - The provision for claims was $4.6 million in 2025, slightly up from $4.5 million in 2024, indicating stable claims management[171]. - The total reserve for claims at December 31, 2025, was $38.1 million, with approximately $34.6 million reserved for claims without notice[208]. - The company continues to evaluate and adjust its reserve estimates for claims based on historical loss ratios and new information, ensuring adequate coverage for future claims[156]. Market Conditions - The title insurance business is cyclical and seasonal, with premiums fluctuating based on real estate activity and mortgage lending conditions[34][35]. - The demand for title insurance is influenced by the volume of residential and commercial real estate transactions and mortgage financing, which can fluctuate based on economic conditions[66]. - The Mortgage Bankers Association projects 2026 purchase activity to increase by 6.4% to $1.4 trillion and refinance activity to increase by 9.5% to $760 billion[145]. - The average 30-year fixed mortgage interest rates were 6.6% in 2025 and are projected to decline to 6.1% in 2026[145]. - Regulatory changes and economic conditions, including inflationary pressures and geopolitical conflicts, may impact the Company's investment portfolio and net premiums written[143]. Competition and Market Share - The title insurance industry is highly competitive, with the four largest companies holding over 80% of the market share in the United States[48]. - The title insurance industry is highly competitive, with key factors including service quality, pricing, expertise, and financial strength[73]. - The Company faces high competition for skilled personnel, which is critical for supporting future growth plans[76]. Regulatory Environment - The Company is subject to various regulatory examinations and potential changes in regulations that could impact its operations[44]. - Regulatory changes, particularly from the CFPB and state regulators, could adversely affect the Company's operations and financial condition[80][81]. - Title insurance rates are regulated and require pre-approval for changes, potentially limiting the Company's pricing flexibility[86]. Cybersecurity and Risk Management - The Company is exposed to cybersecurity risks, which could disrupt operations and result in financial losses[92][100]. - The Company’s investments in cybersecurity include advanced data loss prevention measures and continuous monitoring to safeguard sensitive information[115]. - The Company has established a comprehensive enterprise information security program aligned with the NIST Cybersecurity Framework 2.0 to manage cybersecurity threats[113]. - The Company’s Board of Directors oversees risk management processes, including cybersecurity risks, to align risk exposure with strategic objectives[117]. - The Company’s risk management strategy includes policies and procedures for identifying and mitigating risks associated with title insurance policies and other operational risks[107]. Employee and Corporate Structure - The Company had 548 full-time employees and 26 part-time employees as of December 31, 2025[55]. - The Company is committed to maintaining high-quality employee compensation and benefits to attract and retain key personnel[58]. - The Company relies on its subsidiaries for dividends, with approximately $121.4 million of consolidated shareholders' equity representing net assets that cannot be transferred to the Company[88]. Investment Portfolio - The Company's investment portfolio is primarily composed of municipal and federal U.S. government securities, investment grade corporate fixed maturity securities, and equity securities[51]. - The Company's investment portfolio, which includes fixed maturity securities and equity securities, is subject to risks from economic conditions and market fluctuations, potentially impacting net income[89]. - The Company’s investment portfolio is managed internally and via a wholly owned subsidiary, with securities subject to economic conditions and market risks[51]. Corporate Governance - The Company has goodwill and other intangible assets comprising approximately 5.8% of total assets as of December 31, 2025, which may be subject to impairment charges due to economic downturns[78]. - The Company has a current dividend policy anticipating quarterly dividends, subject to the discretion of the Board of Directors and dependent on future earnings and financial condition[124]. - As of December 31, 2025, the Company had authority remaining under its repurchase plan to purchase up to 413,177 shares of its common stock[125]. Legal Matters - The Company’s legal proceedings are considered incidental to its business and are not expected to materially impact its consolidated financial condition or operations[120].

Environmental Regulations - As of January 1, 2015, ships operating within designated Emission Control Areas (ECAs) must not use fuel with sulfur content exceeding 0.1% m/m, with additional costs anticipated for compliance [64]. - The IMO has established new nitrogen oxide emissions standards, with Tier III standards applicable to ships built on or after January 1, 2016, in North American and U.S. Caribbean Sea ECAs [65]. - By 2025, all new ships are required to be 30% more energy efficient than those built in 2014, with amendments to the Energy Efficiency Design Index (EEDI) effective from April 1, 2022 [67]. - The International Maritime Organization (IMO) has introduced requirements to reduce carbon intensity through the Energy Efficiency Existing Ship Index (EEXI) and operational carbon intensity indicators (CII) for ships over 400 gross tonnage [68]. - Compliance with the revised standards may incur significant costs, including the installation of emission control systems, impacting the company's financial condition [70]. - The Ballast Water Management Convention requires ships to manage ballast water to prevent the spread of invasive species, with compliance deadlines and standards established since 2019 [79]. - Ships over 400 gross tons must comply with the D-1 and D-2 standards for ballast water management, with the D-2 standard requiring treatment systems to eliminate unwanted organisms [80]. - The IMO's data collection system for fuel oil consumption became mandatory for ships over 5,000 gross tonnage starting January 1, 2019, contributing to greenhouse gas emission reduction strategies [66]. - The company plans to invest in its fleet to improve fuel efficiency and comply with revised environmental standards through its comprehensive IMO 2023 plan [70]. - The European Union regulations require companies with ships over 5,000 gross tonnage to monitor and report carbon dioxide emissions annually, potentially incurring additional expenses [101]. - The European Union aims to reduce net greenhouse gas emissions by at least 55% by 2030 compared to 1990 levels, impacting shipping companies with new compliance costs [103]. - Starting January 1, 2024, the EU's carbon market will cover CO2 emissions from all large ships entering EU ports, requiring shipowners to buy permits for emissions [108]. - The Maritime Fuel Regulation mandates a 2% reduction in greenhouse gas emissions from covered vessels starting January 1, 2025, with further reductions every five years, targeting an 80% reduction by January 1, 2050 [103]. - The International Maritime Organization (IMO) aims to reduce total annual GHG emissions from international shipping by at least 20% by 2030 and 70% by 2040 compared to 2008 levels [107]. - The company is committed to reducing its carbon footprint by transitioning to low-carbon fuels while maintaining service delivery [105]. - The IMO Net-zero Framework, expected to be approved in Spring 2026, will require ships to reduce their annual greenhouse gas fuel intensity [107]. Financial Implications - Compliance with the EPA and U.S. Coast Guard regulations may require substantial costs for installing ballast water treatment equipment or implementing disposal procedures [100]. - The company maintains pollution liability coverage insurance of $1.0 billion per incident for each vessel, which may be insufficient in the event of a catastrophic spill [96]. - The company expects to perform thirteen special surveys in 2026 at an aggregate total cost of approximately $15.7 million and two intermediate surveys at a cost of approximately $3.0 million [121]. - Compliance with the Maritime EU ETS will incur additional costs for the company, which cannot be precisely predicted at this time [110]. - The company’s credit facilities impose operating and financial restrictions, including maintaining a consolidated leverage ratio of not more than 200% and a minimum liquidity of not less than $18 million [295]. - The company’s long-term COAs may result in significant fluctuations in quarterly results, potentially affecting liquidity and the ability to meet financial obligations [302]. - The company may incur a 2% United States federal income tax on shipping income attributable to transport of cargoes to or from the United States if not entitled to exemption under section 883 of the Code [329]. - The company is subject to significant legal, accounting, and other expenses as a result of being a public company, which may strain its resources [307]. - The company may need to raise additional capital in the future, which could dilute existing shareholders' interests and may not be available on favorable terms [340]. Operational Risks - The company does not carry loss-of-hire insurance, which could lead to significant financial impacts during extended vessel off-hire periods [279]. - Labor interruptions, such as strikes or work stoppages, could materially affect the company's operations and financial condition [272]. - The company’s reliance on COAs for revenue means it may face operational risks if it cannot fulfill contractual obligations due to factors beyond its control [303]. - The company is subject to counterparty risks in various contracts, including COAs and charters, which could lead to significant losses if counterparties fail to meet their obligations [286]. - The company’s growth strategy involves expanding its fleet, which may require additional financing and could lead to increased operational risks and expenses [299]. - The company manages market exposure using forward freight agreements (FFAs) and other derivatives, which may lead to material fluctuations in results if market movements are not correctly anticipated [300]. - The company’s vessels must undergo regulatory surveys every 30 to 60 months, and failure to pass inspections could result in loss of revenues [308]. - The company relies on key executives, and their loss could have a material adverse effect on its business and financial condition [318]. Market and Competitive Environment - The international shipping industry is highly competitive, and the company may struggle to charter vessels at reasonable rates due to competition from larger operators [271]. - The logistics industry presents risks related to infrastructure, operational efficiencies, and labor relations, which could hinder the company's ability to provide solutions [280]. - The company expects to derive a significant part of its revenue and cash flow from a relatively small number of repeat customers, with the top ten customers representing 35% of total revenue for the year ended December 31, 2025 [283]. - The company participates in various capacities within the dry bulk shipping industry, including as a ship owner, operator, and manager [137]. Taxation and Compliance - The Company is classified as a non-resident of Bermuda for exchange control purposes, allowing for unrestricted transfer of funds into and out of Bermuda [130]. - The Company is subject to U.S. federal income taxation unless exempt under Section 883 of the Internal Revenue Code, which requires meeting specific stock ownership criteria [150]. - There is a risk that the company could lose the Section 883 exemption if 5% Shareholders own 50% or more of the outstanding common shares for more than half the days during the taxable year [158]. - If the 5 Percent Override Rule is triggered, the company may still qualify for the Section 883 exemption if it can demonstrate sufficient qualified shareholders [159]. - The maximum effective rate of U.S. federal income tax on the company's U.S. source shipping income would not exceed 2% under the 4% gross basis tax regime [161]. - If the Section 883 exemption is unavailable, U.S. source shipping income considered "effectively connected" with a U.S. trade or business would be subject to a 21% federal corporate income tax [162]. - Distributions made by the company to U.S. Holders will generally constitute dividends, which may be taxable as ordinary income or "qualified dividend income" depending on certain conditions [168]. - There is no assurance that any dividends paid will be eligible for preferential tax rates for U.S. Individual Holders [170]. - If treated as a Passive Foreign Investment Company (PFIC), U.S. Holders would face different taxation rules, including the option to make a Qualified Electing Fund (QEF) Election [175]. - The company is subject to special rules for Non-Electing Holders, including taxation on excess distributions and gains realized on the sale of common shares [179]. - Non-U.S. Holders generally will not be subject to U.S. federal income or withholding tax on dividends unless connected with a U.S. trade or business [182]. - The European Union has agreed to implement a global corporate minimum tax rate of 15% effective from 2024 for companies with revenues of at least €750 million [190]. - The OECD's two-pillar project aims to implement a global minimum tax rate of 15% for multinational corporations with annual revenue of €750 million or more, which could increase the company's tax compliance burden and global effective tax rate [331]. Cybersecurity and Technology - New cybersecurity regulations require vessel owners to implement cybersecurity measures for ships contracted for construction on or after January 1, 2024 [78]. - The company has not experienced any material cybersecurity incidents that would require disclosure under SEC guidelines as of the date of the annual report [337]. - Cybersecurity risks are heightened due to ongoing global conflicts, potentially impacting the company's operations and financial results [336]. - The company has integrated artificial intelligence into its operations and established an AI team to govern its use, but the full impact of AI on the industry remains uncertain [333]. - The company relies on its IT systems for critical operations, and failures or cybersecurity breaches could disrupt business and increase operating costs [332]. Shareholder and Market Dynamics - The company is classified as a "smaller reporting company," which allows for reduced disclosure requirements that may affect the attractiveness of its common shares to investors [304]. - Future sales of common shares could lead to a decline in market price and dilute shareholders' interests [338]. - The market price of common shares could decline due to large sales by shareholders or the perception of such sales, complicating future equity offerings [338]. - The company may issue additional common shares to support growth strategies, which could dilute existing shareholders' ownership [339].

Revenue and Financial Performance - Agenus recognized approximately $4.2 million in pre-commercial product revenue for the year ended December 31, 2025, from sales of BOT+BAL through early access pathways [462]. - Non-cash royalty revenue related to the sale of future royalties increased by $7.6 million to approximately $108.6 million for the year ended December 31, 2025, due to increased net sales of GSK's vaccines containing the QS-21 adjuvant [463]. - The accumulated deficit as of December 31, 2025, was $2.18 billion, indicating significant losses since inception [460]. - The company has raised approximately $2.05 billion through various financing methods since inception, including common and preferred stock sales and royalty monetization transactions [481]. - Future cash requirements are estimated at $687.0 million for ongoing clinical trials and regulatory efforts, with $628.0 million already expensed as R&D costs [488]. - Net cash used in operating activities was $77.2 million for the year ended December 31, 2025, a decrease from $158.3 million in 2024, highlighting the company's ongoing cash flow challenges [490]. - Cash and cash equivalents decreased to $3.0 million as of December 31, 2025, down from $40.4 million in 2024, indicating a need for additional capital to support operations [484]. Research and Development - Research and development expenses decreased by 49% to $79.3 million for the year ended December 31, 2025, from $155.5 million for the year ended December 31, 2024 [464]. - Research and development (R&D) expenses totaled $79.3 million for the year ended December 31, 2025, a decrease from $155.5 million in 2024, with significant costs attributed to antibody programs and other R&D initiatives [472]. - The lead clinical program, botensilimab (BOT), received Fast Track designation from the FDA for treating patients with specific types of metastatic colorectal cancer [444]. - Agenus has collaborations with several companies, including Bristol-Myers Squibb and Merck, resulting in over a dozen antibody pre-clinical or clinical development programs [445]. - The company is focused on developing its saponin-based vaccine adjuvant platform, particularly the next-generation cultured plant cell QS-21 [455]. Expenses and Losses - General and administrative (G&A) expenses decreased by 24% to $54.4 million for the year ended December 31, 2025, down from $71.9 million in 2024, primarily due to a $9.1 million decrease in personnel-related expenses [466]. - Non-operating expenses increased by $8.1 million, resulting in a net expense of $2.2 million for the year ended December 31, 2025, compared to income of $5.8 million in 2024, mainly due to a $3.5 million loss on the deconsolidation of a foreign subsidiary [467]. - The company has incurred significant losses and is likely to continue doing so until it becomes a commercial entity generating profits [460]. - The accumulated deficit reached $2.18 billion as of December 31, 2025, with expectations of continued significant losses in the coming years as the company advances its technologies and product candidates [481]. Debt and Liabilities - Long-term debt amounts to $36.764 billion, with no payments due in the 1-3 years, 3-5 years, or beyond 5 years [492]. - Operating leases total $16.897 billion, with $2.396 billion due within 1 year, $4.897 billion in 1-3 years, $4.505 billion in 3-5 years, and $5.099 billion beyond 5 years [492]. - Finance leases are recorded at $127 million, with $110 million due within 1 year and $17 million in 1-3 years [492]. Currency and Interest Rate Exposure - Approximately 4.7% of cash used in operations for the year ended December 31, 2025, was from foreign subsidiaries, indicating exposure to foreign currency exchange rate fluctuations [501]. - The company does not currently employ specific strategies to manage foreign currency exchange rate risks, such as derivatives or hedging [501]. - The investment policy aims to preserve principal, maintain liquidity, and maximize yields, prohibiting investments in structured vehicles and asset-backed commercial paper [503]. - The company is exposed to fluctuations in interest rates as it seeks debt financing and invests excess cash [502]. - Non-cash interest expense related to royalty financing transactions is recorded based on estimated royalty payments, which may vary due to several factors [497]. - The company periodically assesses expected royalty payments using historical results and market forecasts, adjusting amortization of liabilities as necessary [498]. Other Significant Events - Incyte has terminated the OX40 program and intends to terminate the entire collaboration agreement by February 2026, reverting rights back to Agenus [446]. - The gain from the deconsolidation of MiNK Therapeutics, Inc. was $100.9 million for the year ended December 31, 2025, reflecting the loss of control in Q3 2025 [468]. - Interest expense decreased to $55.3 million for the year ended December 31, 2025, from $117.6 million in 2024, mainly due to reduced non-cash interest related to the Royalty Purchase Agreement [470].

Capital Requirements and Regulatory Compliance - Green Dot Corporation and Green Dot Bank are required to maintain a capital conservation buffer of 2.5% to avoid restrictions on capital distributions [76]. - As of December 31, 2025, Green Dot Corporation and Green Dot Bank's regulatory capital ratios were above the well-capitalized standards [79]. - Green Dot Corporation expects to continue exceeding all applicable well-capitalized regulatory capital requirements on a fully phased-in basis [80]. - The capital conservation buffer is currently at its fully phased-in level of 2.5% [87]. - Green Dot Bank's deposits are insured by the DIF up to a maximum of $250,000 per depositor [103]. - Green Dot Bank's CRA compliance is evaluated under an approved strategic plan covering 2024 to 2028, focusing on community development lending and investment [102]. - Federal banking regulators may prohibit dividend payments if they deplete a banking organization's capital base to an inadequate level [85]. - Green Dot Corporation may be required to provide financial assistance to Green Dot Bank if it experiences financial distress [92]. - Green Dot Bank has less than $10 billion in total consolidated assets, making it subject to examination by the Federal Reserve for compliance with consumer financial laws [115]. Technology and Operational Risks - The company must effectively manage and scale its technology systems to continue providing and enhancing its products and services [170]. - Green Dot Bank's technology platforms are continuously evolving, which may lead to service disruptions despite significant investments in planning and testing [176]. - The company relies on efficient and uninterrupted operation of its computer network systems and third-party processors to manage large transaction volumes [174]. - The company has experienced operational issues with third-party call centers, which could negatively impact customer support and business operations [185]. - The company relies on third-party vendors for critical services, and disruptions in these services could lead to significant operational challenges [183]. Regulatory and Compliance Challenges - The company is subject to extensive supervision by the Federal Reserve Board and the State of Utah DFI, which may limit business opportunities and increase compliance challenges [187]. - The company has increased investments in regulatory and compliance infrastructure in response to heightened regulatory scrutiny [187]. - The company may face significant financial consequences and reputational damage due to potential data security breaches and regulatory penalties [180]. - The company must comply with evolving privacy and data protection laws, which can be costly and impede the development of new products [182]. - The company may face increased regulatory oversight and compliance costs due to potential changes in laws and regulations affecting the financial services industry [192]. Financial Performance and Revenue Streams - Interchange revenues represented 9% of total operating revenues for the year ended December 31, 2025, and are expected to remain significant [197]. - Future interchange revenues may be adversely affected by regulatory changes or actions by payment networks, necessitating adjustments to the company's fee structure [198]. - The company incurred a civil money penalty of $44 million as part of a Consent Order with the Federal Reserve Board in July 2024 [199]. - The company issued senior unsecured notes totaling $65.0 million in 2024 and 2025, maturing in September 2029, increasing debt service obligations [204]. - The company’s ability to generate cash flow may fluctuate, affecting its capacity to meet debt obligations [206]. - The company’s stock price may decline if actual operating results fall below investor expectations [207]. Intellectual Property and Market Risks - The company has 18 issued patents, but faces risks related to the protection of its intellectual property rights [201]. - The electronic payments industry, including Green Dot's services, is heavily influenced by consumer spending trends, which may be negatively impacted by economic conditions [169]. - A decline in the use of prepaid cards or demand deposit accounts could negatively impact Green Dot's operating revenues [172]. - The company is exposed to risks related to international operations, including regulatory compliance and geopolitical instability [188]. - The company may require additional capital in the future, which may not be available on acceptable terms, potentially impacting operations [203].

Clinical Development - The company is advancing RLYB116, a C5 inhibitor, which has completed two Phase 1 clinical trials demonstrating significant tolerability improvements and sustained inhibition of terminal complement[27][28] - RLYB332, a long-acting MTP-2 antibody for treating iron overload diseases, is in preclinical development and aims to address significant unmet needs in patients with severe anemia[31] - RLYB116 has shown significant improvement in tolerability and complete inhibition of terminal complement in Phase 1 clinical trials[50] - RLYB116 levels exceed C5 by a ratio greater than 2:1 within 12 hours of a 300mg dose, administered once weekly[56] - Non-clinical studies of RLYB332 demonstrated favorable tolerability and sustained pharmacodynamic effects, supporting its development[61] Strategic Alliances and Collaborations - The company has entered into a strategic alliance with AbCellera to co-develop up to five rare disease therapeutic targets, focusing on unmet needs in rare metabolic diseases[33] - A strategic alliance with AbCellera aims to discover and commercialize novel antibody-based therapeutics for rare diseases[62] - The company has entered into a Product License Agreement (PLA) with Affibody, granting non-exclusive and exclusive rights for the use of Affibody ligands for human therapeutic use[78] - The company has a collaboration agreement with Johnson & Johnson, which includes an upfront payment of $0.5 million and potential additional payments based on study triggers[98] Financial Aspects and Market Opportunities - Concurrent financing related to the merger includes a commitment of approximately $505.5 million from investors for shares of Candid common stock[19] - The company received $20.0 million from the sale of its interest in the ENPP1 program, including $7.5 million upfront and $12.5 million from a milestone payment[32] - The company estimates over 25,000 cases of immune platelet transfusion refractoriness (PTR) annually in the U.S. and major markets, highlighting a substantial market opportunity[39] - Current treatments for PTR are expensive and challenging, indicating a need for more accessible and effective solutions[40] Merger and Acquisition Details - The merger with Candid is expected to result in pre-Merger equityholders of Candid owning approximately 57.55% of the combined company, while Rallybio's pre-Merger equityholders will own about 3.65%[21] - The proposed merger with Candid could result in a termination fee of $1.425 million and expense reimbursement of up to $500,000 if not completed[210] - Following the merger, existing securityholders of the company are expected to own approximately 3.65% of the combined company, while former Candid securityholders are expected to own approximately 96.35%[213] - The merger is contingent on satisfying specific conditions, and failure to meet these could adversely affect the company's operations and stock price[209] - The company is subject to significant transaction costs related to the merger, regardless of its completion[215] Regulatory Compliance and Approval Processes - Regulatory compliance is critical, as failure to meet FDA requirements may result in delays or refusal of product approvals[105] - The FDA application fee for submitting an NDA or BLA for fiscal year 2025 is approximately $4.3 million, with an annual program fee exceeding $403,000 per program[117] - The FDA conducts a preliminary review of all NDAs and BLAs within 60 days of receipt and informs the sponsor by the 74th day whether the application is sufficiently complete for substantive review[118] - The FDA has ten months to complete its initial review of a standard application and six months for priority review applications, with possible extensions of three additional months[119] - The approval process for an NDA or BLA can result in either an approval letter or a Complete Response Letter (CRL), with the latter outlining deficiencies that must be addressed for reconsideration[123] Market and Pricing Dynamics - The downward pressure on healthcare costs has led to increased barriers for new product entry, with significant scrutiny on pricing and reimbursement levels[193] - Third-party payors in the U.S. are increasingly challenging the price and cost-effectiveness of biopharmaceutical products, leading to uncertainty in coverage and reimbursement[189] - In some foreign countries, drug pricing must be approved before marketing, with requirements varying widely and potentially impacting demand[190] Manufacturing and Production - The company relies on third-party contract manufacturers for the production of product candidates, with no current plans to establish internal manufacturing facilities[100] - The company has enhanced the manufacturing process of RLYB116 to improve tolerability and increase dosage[46] - The FDA requires compliance with cGMP regulations for manufacturing, which includes quality control and assurance measures[137] Employment and Operational Structure - As of December 31, 2025, the company employed 14 full-time employees, with 7 engaged in new product sourcing and 7 in administrative functions[204] - The company is winding down general and administrative operations not needed post-merger while continuing limited R&D to maximize the potential value of contingent value rights (CVRs)[34] Risks and Challenges - The company is at risk of losing key personnel during the merger process, which could impact its operations[212] - The completion of the merger is uncertain, and any material adverse changes could negatively impact the stock price of the combined entity[216] - The company may face fines, product recalls, and operational restrictions if it fails to comply with foreign regulatory requirements[187]

Financial Position - As of December 31, 2025, total assets were $4.77 billion, total loans held for investment were $4.08 billion, total deposits were $3.65 billion, and total shareholders' equity was $544.2 million[20]. - Total deposits reached $3.65 billion as of December 31, 2025, with a weighted average deposit cost of 2.63%[57]. - Core deposits accounted for 75.2%, or $2.74 billion, of total deposits as of December 31, 2025[58]. - Brokered deposits increased to $747.8 million as of December 31, 2025, compared to $721.8 million in 2024[59]. - Net loans were 84.4% of total assets and 110.4% of total deposits as of December 31, 2025, compliant with the board's limits[66]. Loan Portfolio - The loan portfolio held for investment as of December 31, 2025, included $1.56 billion in commercial real estate loans, representing 38.3% of the total loan portfolio, an increase from 24.1% in 2024[29]. - The commercial real estate loans acquired from First IC contributed $719.1 million to the portfolio, alongside organic growth of $79.6 million[33]. - The commercial and industrial loans represented $96.4 million, or 2.4% of the total loan portfolio as of December 31, 2025, compared to $78.2 million, or 2.5% in 2024[37]. - The SBA and USDA loan portfolio totaled $439.8 million as of December 31, 2025, reflecting a 76.9% increase from $248.6 million in 2024[43]. - The construction and development loans amounted to $41.8 million, or 1.0% of the total loan portfolio, up from $21.6 million, or 0.7% in 2024[29]. - As of December 31, 2025, the outstanding balance of commercial and industrial SBA loans was $42.4 million, an increase from $28.5 million in 2024, with 49.0% guaranteed by the SBA[44]. - Residential real estate loans totaled $2.38 billion as of December 31, 2025, representing 58.3% of the total loan portfolio held for investment, down from 72.7% in 2024[48]. - The company originated $464.6 million of non-conforming residential mortgage loans in 2025, compared to $413.7 million in 2024, and sold $310.2 million of these loans during the same period[49]. Acquisition and Integration - The acquisition of First IC Corporation was completed on December 1, 2025, with total consideration of approximately $202.3 million, consisting of $90.5 million in equity and $111.9 million in cash[25]. - The integration of First IC Corporation, acquired on December 1, 2025, will require significant management attention and resources, with potential challenges in systems and personnel integration[217]. Capital Requirements and Regulation - The company is required to maintain certain minimum capital levels based on ratios of capital to total assets and capital to risk-weighted assets[91]. - The common equity Tier 1 (CET1) risk-based capital ratio is a key measure, primarily comprised of common stock instruments and retained earnings[92]. - The leverage capital ratio, serving as a minimum capital standard, is set at a required minimum of 4%[93]. - A capital conservation buffer of 2.5% is required above each minimum risk-based capital ratio to absorb losses during economic stress[94]. - As of December 31, 2025, the Bank's regulatory capital ratios were above the applicable well-capitalized standards and met the capital conservation buffer[99]. - The company is subject to comprehensive supervision and regulation by the Federal Reserve under the Bank Holding Company Act[79]. - The company must act as a source of financial and managerial strength to its subsidiary bank[81]. - The Federal Reserve may require bank holding companies to maintain capital ratios substantially in excess of mandated minimum levels based on economic conditions[97]. - Failure to meet minimum capital requirements could result in adverse regulatory actions affecting operations or financial condition[98]. - The company is subject to oversight by various regulatory authorities, including the SEC and FINRA[90]. - The Company exceeded the $3.0 billion asset threshold for the first time in Q4 2021, becoming subject to consolidated risk-based capital requirements starting in 2022[100]. - The minimum capital requirement for the Community Bank Leverage Ratio is set at 9%, but the Bank has not opted into this framework[101]. - The Bank's capital requirements include a 6.5% CET1 to risk-weighted assets, 8.0% Tier 1 capital to risk-weighted assets, and 10.0% total capital to risk-weighted assets[104]. Risk Factors - Increased competition from fintech companies and other financial institutions may pressure the Bank's margins and profitability[145]. - Fluctuations in interest rates significantly impact net interest income, with elevated rates observed during 2024[148]. - Prolonged inflation may negatively affect profitability and demand for products and services, leading to increased default rates[151]. - Negative developments in the banking industry could impact customer confidence and liquidity, potentially requiring the Bank to sell securities at a loss[152]. - The company faces potential increases in deposit insurance costs due to negative developments in the banking industry, which could adversely affect its financial condition and operations[153]. - Liquidity risks are significant, as customer deposits, the primary source of funds, may decrease if customers perceive better investment opportunities, leading to increased funding costs and reduced net interest income[154]. - Approximately 97.6% of the company's loan portfolio is secured by real estate, making it vulnerable to adverse changes in real estate values, which could impair collateral value and increase credit risk[159]. - The company relies heavily on its management team, and the loss of key personnel could adversely impact its strategic initiatives and relationships with customers[167]. - Nonperforming assets negatively affect net income and increase loan administration costs, which could further impact the company's financial condition[169]. - The provision and allowance for credit losses may be insufficient to cover potential losses in the loan portfolio, leading to decreased net income and potential capital constraints[170]. - The company utilizes brokered deposits as a funding source, which may be unstable and could adversely affect its financial position if access to these deposits is restricted[166]. - The SBA lending program is crucial for the company, and any changes in government policy or funding could materially affect its ability to originate and sell SBA loans[161]. - The company may face challenges in meeting unfunded credit commitments, especially during economic stress, which could adversely impact its liquidity and financial condition[165]. - The company’s access to funding sources may be impaired by disruptions in financial markets or negative perceptions about the financial services industry, affecting its ability to capitalize on growth opportunities[156]. - Decreased residential mortgage origination and competitive pricing decisions may adversely affect profitability[171]. - Changes in interest rates could negatively impact the returns and market value of investment securities, potentially leading to realized losses[172]. - The company may face additional risks when implementing or acquiring new lines of business or products, which could affect profitability and operational efficiency[174]. - The focus on a limited demographic segment, particularly Asian-American communities, makes the company vulnerable to adverse economic changes affecting these populations[176]. - Ongoing litigation and regulatory investigations could result in significant costs and adversely affect the company's financial condition and reputation[177]. - The effectiveness of the company's risk management framework may not adequately mitigate risks, potentially leading to unexpected losses[180]. - Rapid technological changes in the financial services industry necessitate effective implementation of new technologies, which may pose operational challenges[181]. - Cybersecurity threats and system failures could lead to increased operating costs and significant liabilities[183]. - Dependence on third-party service providers for essential operations poses risks if these providers experience difficulties or terminate services[188]. - The development and use of artificial intelligence (AI) present regulatory and operational challenges that could adversely impact the company's business[189]. - The company relies on analytical and forecasting models for estimating credit losses and measuring fair value, which may be inadequate during market stress[192]. - Changes in accounting standards could materially impact the company's financial statements and require restatements of prior periods[195]. - The effectiveness of internal controls over financial reporting is crucial, as failures could lead to material adverse effects on business and stock price[196]. - The company is subject to extensive government regulation, which could limit activities and adversely impact asset growth and earnings[197]. - Regulatory examinations may lead to remedial actions if the company's financial condition is deemed unsatisfactory, potentially affecting operations[198]. - Changes in monetary policy by the Federal Reserve could adversely impact the company's operations and financial condition[199]. - Noncompliance with fair lending laws could result in material penalties and negatively affect the company's reputation and financial condition[200]. - The company may face increased deposit insurance premiums, which could adversely affect profitability and operational flexibility[205]. Corporate Governance - Directors and their families hold a 24.6% ownership interest, potentially allowing them to influence corporate actions without broader shareholder consent[206]. - The company's dividend policy may change, impacting the return on investment for shareholders[210]. - The company may need to raise additional capital in the future to meet regulatory capital requirements and maintain sufficient liquidity, which could include financing acquisitions[212]. - The ability to incur debt and pledge assets to secure that debt may impact profitability, as interest payments must be made before dividends to shareholders[214]. - The company intends to evaluate potential acquisitions and expansion opportunities, but risks include undisclosed liabilities, unanticipated costs, and integration challenges[215]. - Future success depends on executing the long-term business strategy, which includes enhancing reputation, attracting personnel, and improving operating efficiency[216]. - Failure to achieve strategic objectives could adversely affect business growth, financial condition, and results of operations[217].

Company Overview - PLAYSTUDIOS, Inc. has developed a portfolio of free-to-play social casino games, including Tetris®-branded mobile games, and acquired Brainium in late 2022[359]. Revenue Generation - The company generates revenue primarily from in-game virtual currency sales, with a significant concentration in North America, and also from in-game advertising, particularly in Tetris® and Brainium games[362][363]. - Revenue from virtual currency is recognized as it is consumed, with an average consumption period of approximately one day, based on player behavior analysis[431]. - The company recognizes advertising revenue at the point in time when advertisements are displayed or offers are completed, with payment terms typically ranging from 45 to 60 days[433][434]. Player Engagement and Metrics - The playAWARDS program incorporates loyalty points earned by players, with most rewards provided at no cost to the company, enhancing player engagement and retention[360][365]. - Average Daily Active Users (Average DAU) and Average Monthly Active Users (Average MAU) are key metrics used to measure player engagement, with DAU defined as the number of individuals playing a game on a given day[367][368]. - Average Daily Paying Users (Average DPU) measures the number of individuals making purchases within games, providing insight into monetization trends[370]. - Average Daily Payer Conversion is calculated as Average DPU divided by Average DAU, helping to understand the monetization of active players[371]. - Average Daily Revenue Per DAU (ARPDAU) is used to assess overall monetization, calculated as game-related and advertising revenue divided by Average DAU[372]. - The playAWARDS loyalty platform's Available Rewards metric indicates the breadth of the loyalty offering, measuring the average number of unique rewards available[374]. - Purchases metric tracks the total number of rewards exchanged for loyalty points, reflecting audience interest and engagement with the playAWARDS platform[375]. Financial Performance - Net revenue for the year ended December 31, 2025, was $235.1 million, a decrease of $54.3 million or 18.8% compared to $289.4 million in 2024[380]. - Operating expenses decreased by $63.3 million or 19.6% to $259.0 million in 2025 from $322.3 million in 2024[385]. - playGAMES revenue was $234.1 million in 2025, down $55.3 million or 19.1% from $289.4 million in 2024, primarily due to a $40.5 million decrease in virtual currency revenue[382]. - playAWARDS net revenue increased to $1.0 million in 2025, a significant rise of $946 thousand or 1525.8% from $62 thousand in 2024[384]. - Average Daily Active Users (DAU) for playGAMES decreased by 795 to 2,305 in 2025, a decline of 25.6% compared to 3,100 in 2024[382]. - Retail Value of Purchases in playAWARDS decreased by $54.8 million or 48.0% to $59.4 million in 2025 from $114.1 million in 2024[384]. - Total operating loss for 2025 was $23.9 million, an improvement of $8.9 million or 27.2% from a loss of $32.9 million in 2024[380]. - Cost of revenue decreased by $15.2 million or 21.0% to $57.5 million in 2025 from $72.7 million in 2024[386]. - Selling and marketing expenses decreased by $9.1 million or 14.2% to $55.5 million in 2025 from $64.6 million in 2024[387]. - Income tax expense for 2025 was approximately $1.9 million, reflecting an effective income tax rate of negative 7.3%[394]. - playGAMES AEBITDA decreased to $58.6 million in 2025 from $85.1 million in 2024, a decline of 31.1%[397]. - playGAMES AEBITDA margin was 25.1% in 2025, down from 29.4% in 2024, reflecting a 4.3% decrease[397]. - playAWARDS AEBITDA improved to $(8.7) million in 2025 from $(13.7) million in 2024, indicating a reduction in losses[398]. - Consolidated AEBITDA for 2025 was $35.6 million, down from $56.5 million in 2024, a decrease of 37.1%[402]. - Consolidated AEBITDA margin decreased to 15.1% in 2025 from 19.5% in 2024[402]. - Net revenue fell to $235.1 million in 2025 from $289.4 million in 2024, a decline of 18.7%[402]. - Net loss for 2025 was $(28.6) million, slightly improved from $(28.7) million in 2024[402]. Cash and Assets - Cash and cash equivalents as of December 31, 2025, were $104.9 million, with an additional $0.6 million in restricted cash[403]. - Net cash provided by operating activities was $26.3 million in 2025, down from $45.7 million in 2024[414]. - Total net cash used in financing activities decreased to $14.9 million in 2025 from $41.9 million in 2024, primarily due to reduced share repurchases[416]. - As of December 31, 2025, the company's goodwill totaled $52.2 million, with no impairment required following the annual assessment conducted on October 1, 2025[421][422]. - The company applies ASC 805 for business combinations, allocating fair value to tangible and intangible assets, with excess purchase consideration recorded as goodwill[423]. Risk Factors - The company is exposed to foreign currency risks, particularly from transactions in currencies other than the U.S. Dollar, which could materially impact future operating results[444][445]. - The company has not had any borrowings outstanding under its Credit Agreement as of December 31, 2025, indicating no interest rate risk exposure[440]. - Significant estimates in valuing intangible assets include future expected cash flows and discount rates, which are inherently uncertain[424]. - The company does not purchase or hold derivative financial instruments for trading purposes, minimizing investment risk[441]. - The company assesses player behavior continuously to refine its revenue recognition estimates and assumptions[432].

IPO and Fundraising - The company completed its Initial Public Offering on June 27, 2025, issuing 27,600,000 Class A ordinary shares at a price of $10.00 per share, generating gross proceeds of $276,000,000[25]. - An additional $5,800,000 was raised through the sale of Private Placement Shares at the same price of $10.00 per share[26]. - The total net proceeds of $276 million from the IPO and Private Placement were placed in a Trust Account, which may only be invested in U.S. government securities or held as cash[142]. - As of December 31, 2025, the company has approximately $281,884,000 available for the Business Combination from the Trust Account[65]. - As of December 31, 2025, the company had $25,000 in cash in its operating account, compared to $0 in 2024, indicating a significant increase in liquidity[161]. - The Sponsor has committed to loan the company up to $1,750,000 to finance transaction costs related to the Business Combination, with approximately $312,000 drawn as of December 31, 2025[162]. Business Combination - The company has until June 27, 2027, to complete the Business Combination, or it will liquidate and redeem Public Shares at a price equal to the amount in the Trust Account[29]. - The Business Combination Agreement with AIR was executed on November 7, 2025, which will result in shareholders receiving one Pubco Ordinary Share for each Class A ordinary share held[32][33]. - The company anticipates that the post-Business Combination entity will own or acquire 100% of the equity interests or assets of the target business[42]. - The Business Combination may be financed through cash, debt, equity securities, or a combination of these, providing flexibility in structuring the deal[66]. - The company may seek additional financing through private offerings of debt or equity securities to complete the Business Combination, which could lead to dilution for public shareholders[68]. - The company is focused on acquiring businesses in sectors such as financial services, digital assets, healthcare, real estate services, technology, and software[149]. - The company entered into a Business Combination Agreement on November 7, 2025, which will result in shareholders receiving Pubco Ordinary Shares[157]. Redemption and Shareholder Rights - The redemption price for Public Shares upon completion of the Business Combination is set at $10.36 per share, including $0.15 per share from the Sponsor Note[87]. - The company will provide Public Shareholders the opportunity to redeem all or a portion of their Public Shares upon completion of the Business Combination, either through a general meeting or a tender offer[88]. - If the Business Combination is not completed, Public Shareholders who elected to redeem their shares will not receive any redemption for their shares[102]. - The company may limit redemption rights to 15% of Public Shares for shareholders acting in concert, to prevent large blocks of shares from being used to block the Business Combination[98]. - If the Business Combination is not completed by the end of the Combination Period, Public Shareholders may receive only $10.36 per share, which includes $0.15 per share from the Sponsor Note[doc id='124']. Financial Performance - For the year ended December 31, 2025, the company reported a net income of approximately $3,605,000, driven by $5,869,000 in interest income, offset by $2,203,000 in general and administrative expenses[167]. - The company incurred a net loss of approximately $61,000 for the year ended December 31, 2024, entirely attributed to general and administrative expenses[168]. - The working capital deficit was approximately $1,888,000 as of December 31, 2025, up from approximately $164,000 in 2024, reflecting increased financial pressure[161]. - The company has not generated any operating revenues to date and will not do so until after the completion of the Business Combination[166]. Corporate Governance - The company is classified as a "controlled company" under Nasdaq standards, allowing it to utilize certain exemptions from corporate governance requirements[202]. - The company has three directors, with terms structured to ensure staggered elections[199]. - The Audit Committee is required to have at least three independent members, but currently has only one member[204]. - The company has not formally established specific minimum qualifications for directors but considers various factors in the nomination process[209]. - The company has agreed to pay cash fees to independent directors of $50,000 per year, payable quarterly[215]. Regulatory and Compliance - The company is classified as an "emerging growth company," allowing it to take advantage of certain exemptions from reporting requirements[60]. - The company will remain an emerging growth company until it meets specific revenue or market capitalization thresholds, including total annual gross revenue of at least $1.235 billion or a market value exceeding $700 million[121]. - The SEC's new SPAC rules, effective July 1, 2024, may materially affect the company's ability to negotiate and complete the Business Combination[doc id='155']. - The company is required to evaluate its internal control procedures for the fiscal year ending December 31, 2026, as mandated by the Sarbanes-Oxley Act[120]. - The company has incurred increased expenses due to being a public company, including legal and compliance costs[166]. Risks and Challenges - The company faces competition from well-established entities in identifying and completing business combinations, which may limit its ability to acquire larger target businesses[116]. - The company may encounter regulatory review and approval requirements that could hinder the completion of the Business Combination[doc id='124']. - The company may pursue business combinations with targets that are financially unstable or in early stages of development, exposing it to inherent risks[66]. - The company faces increased competition for attractive acquisition targets due to a rise in the number of SPACs going public in recent years[doc id='124']. Miscellaneous - The company has not paid any cash dividends to date and does not intend to do so prior to the completion of the Business Combination[136]. - The company has not established any limit on the amount of consulting or management fees that may be paid to directors or management after the Business Combination[218]. - The company has waived rights to liquidating distributions from the Trust Account for Founder Shares or Private Placement Shares if the Business Combination is not completed[105].

Financial Performance - For the year ended December 31, 2025, the company reported a net income of $3,605,405, primarily from interest earned on marketable securities held in the Trust Account amounting to $4,827,356, after deducting general and administrative costs of $1,221,951[283]. - As of December 31, 2025, the company held marketable securities in the Trust Account valued at $120,754,293, which includes approximately $5,179,293 of interest income[289]. Initial Public Offering (IPO) - The company completed its Initial Public Offering on December 5, 2024, raising gross proceeds of $100,000,000 from the sale of 10,000,000 Units at $10.00 per Unit[284]. - The company incurred $3,605,995 in costs related to the Initial Public Offering, which included a cash underwriting fee of $2,300,000[285]. - Following the Initial Public Offering, the company placed $100,500,000 in the Trust Account, which includes net proceeds from the sale of Public and Private Placement Units[285]. Financial Position and Needs - As of December 31, 2025, the company had cash of $229,625 and a working capital deficit of $1,053,365, indicating a need for additional funds to support operations[290]. - The company anticipates incurring significant costs in pursuing its acquisition plans and may need to raise additional funds to complete a Business Combination[281][292]. - The company has no long-term debt or off-balance sheet financing arrangements as of December 31, 2025, and has only a monthly obligation of $10,000 for certain administrative services[293][294]. Use of Funds - The company plans to use funds from the Trust Account primarily to complete its Business Combination and may withdraw interest to pay taxes[289]. - The company has engaged EarlyBirdCapital, Inc. as an advisor for its Business Combination, agreeing to pay a cash fee of 3.5% of the gross proceeds of the Initial Public Offering upon consummation[296].